Acquisitions and Divestitures (Tables)

6 Months Ended

Jun. 30, 2013

Unaudited Pro Forma Results of Operations

The following table presents the unaudited pro forma consolidated operating results for the Company, as though the Actavis Group acquisition had occurred as of the beginning of the prior annual reporting period. The unaudited pro forma results reflect certain adjustments related to past operating performance, acquisition costs and acquisition accounting adjustments, such as increased depreciation and amortization expense based on the fair valuation of assets acquired, the impact of acquisition financing in place at January 1, 2012 and the related tax effects. The pro forma results do not include any anticipated synergies which may be achievable subsequent to the acquisition date. Accordingly, such pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the dates indicated, nor are they indicative of the future operating results of the combined company (in millions; except per share amounts):

	Three Months Ended			Six Months Ended
	June 30, 2012			June 30, 2012
Net revenues	$	2,003.3		$	4,150.6
Net income attributable to common shareholders	$	(78.8	)	$	(73.5	)
Earnings (loss) per share:
Basic	$	(0.60	)	$	(0.56	)
Diluted	$	(0.60	)	$	(0.56	)

Uteron Pharma, SA [Member]

Allocation of Consideration Transferred

The following table summarizes the preliminary fair values of the tangible and identifiable intangible assets acquired and liabilities assumed at acquisition date, with the excess being allocated to goodwill. At June 30, 2013, certain amounts have not been finalized including intangible asset values, uncertain tax positions, as well as evaluation of contingencies. The finalization of these matters may result in changes to the goodwill and the Company expects to finalize such matters in the second half of 2013.

(in millions)	Amount
Accounts receivable	$	1.6
Other current assets		1.2
Property, plant & equipment		5.7
Other long term assets		0.5
IPR&D intangible assets		250.0
Goodwill		26.4
Current liabilities, excluding current portion of debt		(8.0	)
Long-term deferred tax and other tax liabilities		(82.5	)
Contingent consideration		(43.4	)
Debt		(5.2	)
Other long-term liabilities		(4.3	)
Net assets acquired	$	145.0

Actavis Group [Member]

Allocation of Consideration Transferred

At June 30, 2013, certain amounts have not been finalized including intangible asset values, uncertain tax positions as well as evaluation of contingencies pending the finalization of the Company’s evaluation of certain matters in connection with historical rebate programs. The finalization of these matters may result in changes to the goodwill and the Company expects to finalize such matters in the second half of 2013.

(in millions)	Amount
Cash and cash equivalents	$	110.5
Accounts receivable		527.9
Inventories		680.1
Other current assets		286.2
Property and equipment		763.0
Other long term assets		16.9
IPR&D intangible assets		272.9
Intangible assets		2,268.0
Goodwill		2,895.2
Current liabilities		(1,396.5	)
Long-term deferred tax and other tax liabilities		(742.4	)
Other long term liabilities		(176.0	)
Long-term debt		(14.1	)
Noncontrolling interests		(21.9	)
Net assets acquired	$	5,469.8